Despite the inherent limitations of the current study due to the relatively limited sample size and lack of validation in a broader population, the results indicate that transcriptional profiling can be a valuable method for identifying biomarkers that are involved in the pathogenesis of CARD11+ and CARD11– CRC. This evidence concerns the gene CARD11 and colorectal carcinoma.